Literature DB >> 23908514

Polymyalgia rheumatica: pathogenesis and management.

Sarah Louise Mackie1.   

Abstract

Entities:  

Keywords:  Polymyalgia rheumatica (PMR); giant cell arteritis (GCA); management; pathogenesis

Mesh：

Substances：

Year:  2013        PMID： 23908514      PMCID： PMC4954311          DOI： 10.7861/clinmedicine.13-4-398

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  20 in total

1.  Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice.

Authors:  M C van der Goes; J W G Jacobs; M Boers; T Andrews; M A M Blom-Bakkers; F Buttgereit; N Caeyers; M Cutolo; J A P Da Silva; L Guillevin; J R Kirwan; J Rovensky; G Severijns; S Webber; R Westhovens; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2010-08-06       Impact factor: 19.103

2.  BSR and BHPR guidelines for the management of polymyalgia rheumatica.

Authors:  Bhaskar Dasgupta; Frances A Borg; Nada Hassan; Kevin Barraclough; Brian Bourke; Joan Fulcher; Jane Hollywood; Andrew Hutchings; Valerie Kyle; Jennifer Nott; Michael Power; Ash Samanta
Journal:  Rheumatology (Oxford)       Date:  2009-11-12       Impact factor: 7.580

3.  The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain.

Authors:  M A Gonzalez-Gay; C Garcia-Porrua; C Salvarani; I Olivieri; G G Hunder
Journal:  J Rheumatol       Date:  2000-09       Impact factor: 4.666

4.  The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases.

Authors:  Cynthia S Crowson; Eric L Matteson; Elena Myasoedova; Clement J Michet; Floranne C Ernste; Kenneth J Warrington; John M Davis; Gene G Hunder; Terry M Therneau; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2011-03

5.  2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Authors:  Bhaskar Dasgupta; Marco A Cimmino; Hilal Maradit Kremers; Wolfgang A Schmidt; Michael Schirmer; Carlo Salvarani; Artur Bachta; Christian Dejaco; Christina Duftner; Hanne Slott Jensen; Pierre Duhaut; Gyula Poór; Novák Pál Kaposi; Peter Mandl; Peter V Balint; Zsuzsa Schmidt; Annamaria Iagnocco; Carlotta Nannini; Fabrizio Cantini; Pierluigi Macchioni; Nicolò Pipitone; Montserrat Del Amo; Georgina Espígol-Frigolé; Maria C Cid; Víctor M Martínez-Taboada; Elisabeth Nordborg; Haner Direskeneli; Sibel Zehra Aydin; Khalid Ahmed; Brian Hazleman; Barbara Silverman; Colin Pease; Richard J Wakefield; Raashid Luqmani; Andy Abril; Clement J Michet; Ralph Marcus; Neil J Gonter; Mehrdad Maz; Rickey E Carter; Cynthia S Crowson; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2012-04

6.  Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study.

Authors:  Maurizio Mazzantini; Claudia Torre; Mario Miccoli; Angelo Baggiani; Rosaria Talarico; Stefano Bombardieri; Ombretta Di Munno
Journal:  J Rheumatol       Date:  2012-01-15       Impact factor: 4.666

7.  Ultrasonography in early assessment of elderly patients with polymyalgic symptoms: a role in predicting diagnostic outcome?

Authors:  P Falsetti; C Acciai; A Volpe; L Lenzi
Journal:  Scand J Rheumatol       Date:  2010-07-24       Impact factor: 3.641

8.  Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation.

Authors:  Colin T Pease; Glenn Haugeberg; Ann W Morgan; Bridget Montague; Elizabeth M A Hensor; Bipin B Bhakta
Journal:  J Rheumatol       Date:  2005-06       Impact factor: 4.666

9.  Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study.

Authors:  G Ferraccioli; F Salaffi; S De Vita; L Casatta; E Bartoli
Journal:  J Rheumatol       Date:  1996-04       Impact factor: 4.666

10.  Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

Authors:  M J van der Veen; H J Dinant; C van Booma-Frankfort; G A van Albada-Kuipers; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1996-04       Impact factor: 19.103
View more
  3 in total

1.  Patients' views on the causes of their polymyalgia rheumatica: a content analysis of data from the PMR Cohort Study.

Authors:  Maatla Tshimologo; Benjamin Saunders; Sara Muller; Christian D Mallen; Samantha L Hider
Journal:  BMJ Open       Date:  2017-01-25       Impact factor: 2.692

2.  (Dis)agreement of polymyalgia rheumatica relapse criteria, and prediction of relapse in a retrospective cohort.

Authors:  Thomas E Bolhuis; Diane Marsman; Frank H J van den Hoogen; Alfons A den Broeder; Nathan den Broeder; Aatke van der Maas
Journal:  BMC Rheumatol       Date:  2022-08-02

3.  The availability of health information to patients with newly diagnosed polymyalgia rheumatica: results from the Polymyalgia Rheumatica (PMR) Cohort study.

Authors:  Maatla Tshimologo; Toby Helliwell; Samantha Hider; Christian Mallen; Sara Muller
Journal:  Prim Health Care Res Dev       Date:  2018-08-08       Impact factor: 1.458
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.